IDXX Q1 2018 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$538M+16.4% YoY

Gross Profit

$303M56.4% margin

Operating Income

$113M21.0% margin

Net Income

$89M16.6% margin

EPS (Diluted)

$1.01

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$11M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.5B

Stockholders' Equity

-$49M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$538M	$462M	+16.4%
Gross Profit	$303M	$258M	+17.4%
Operating Income	$113M	$92M	+22.6%
Net Income	$89M	$69M	+29.6%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$879M80%

Reagent Rental Programs

$116M11%

Instrument Rebate Programs

$64M6%

Extended Warranties And Post Contract Support

$41M4%

Geographic Segments

UNITED STATES

$327M79%

Asia Pacific

$56M13%

CANADA

$23M5%

Latin America

$11M3%